Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Current opinion in allergy and clinical immunology: a change in leadership

Current opinion in allergy and clinical immunology: a change in leadership EDITORIAL URRENT Current opinion in allergy and clinical immunology: PINION a change in leadership Stephanie Fairbairn Welcome to the third issue of Current Opinion in Dr Tarlo continue her excellent work on a grander Allergy and Clinical Immunology in 2018! This issue scale. Please refer to Dr Tarlo’s biography (pp. 000– marks the start of a new era for the journal, as we say 000) for further information on her experience. goodbye and thank you to one Editor-in-Chief and Finally, a thank you to Dr G. Walter Canonica, hello and welcome to another. who continues to edit the journal and marshal Dr Mark Ballow, who has edited the journal this transition. since its inception in 2001, has stepped down as Drs Canonica and Tarlo look to continue to Editor-in-Chief and has passed the baton to Dr Susan build on the success of the journal, maintaining Tarlo. Dr Tarlo will work alongside longstanding the same goal Ballow and Canonica [1] had on its Editor-in-Chief Dr G. Walter Canonica. conception, to ‘better serve [academics] and solidify First, we would like to place on record our sin- the needed bridge of knowledge between the basic cere thanks to Dr Ballow for his work on the journal science and immunology of allergy and primary over the past 17 years. Together with Dr Canonica, immune deficiencies with the clinical aspects of Dr Ballow has led the journal from its conception to disease recognition, evaluation, and treatment’. its current standing: a well respected source of infor- mation with an impact factor of 3.463. Dr Ballow’s Acknowledgements expertise and influence in the allergy and immunol- None. ogy field cannot be underestimated, nor can his commitment and dedication to the journal. He Financial support and sponsorship has been a pleasure to work with and will be a big None. loss to the journal. From all of us here at the editorial office: Mark, you will be missed. Conflicts of interest Second, welcome to Dr Susan Tarlo! Dr Tarlo has There are no conflicts of interest. been with the journal since 2003, working with Dr Piero Maestrelli to edit the very successful section on occupational disease. Dr Tarlo has been a wonderful REFERENCE servant to the journal over the years, and is a natural 1. Ballow M, Canonica GW. An introduction to current opinion in allergy and clinical immunology. Curr Opin Allergy Clin Immunol 2001; 1:1. successor to Dr Ballow. We look forward to seeing Health Learning, Research & Practice, Wolters Kluwer, London, UK Correspondence to Stephanie Fairbairn, Managing Editor, Health Learn- ing, Research & Practice, Wolters Kluwer, Citi Building, 41st Floor, 25 Canada Square, Canary Wharf, London E14 5LQ, UK. E-mail: Stephanie.Fairbairn@wolterskluwer.com Curr Opin Allergy Clin Immunol 2018, 18:167 DOI:10.1097/ACI.0000000000000449 1528-4050 Copyright  2018 Wolters Kluwer Health, Inc. All rights reserved. www.co-allergy.com Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Allergy and Clinical Immunology Wolters Kluwer Health

Current opinion in allergy and clinical immunology: a change in leadership

Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/current-opinion-in-allergy-and-clinical-immunology-a-change-in-5tuf2WfobA

References (2)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1528-4050
eISSN
1473-6322
DOI
10.1097/ACI.0000000000000449
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL URRENT Current opinion in allergy and clinical immunology: PINION a change in leadership Stephanie Fairbairn Welcome to the third issue of Current Opinion in Dr Tarlo continue her excellent work on a grander Allergy and Clinical Immunology in 2018! This issue scale. Please refer to Dr Tarlo’s biography (pp. 000– marks the start of a new era for the journal, as we say 000) for further information on her experience. goodbye and thank you to one Editor-in-Chief and Finally, a thank you to Dr G. Walter Canonica, hello and welcome to another. who continues to edit the journal and marshal Dr Mark Ballow, who has edited the journal this transition. since its inception in 2001, has stepped down as Drs Canonica and Tarlo look to continue to Editor-in-Chief and has passed the baton to Dr Susan build on the success of the journal, maintaining Tarlo. Dr Tarlo will work alongside longstanding the same goal Ballow and Canonica [1] had on its Editor-in-Chief Dr G. Walter Canonica. conception, to ‘better serve [academics] and solidify First, we would like to place on record our sin- the needed bridge of knowledge between the basic cere thanks to Dr Ballow for his work on the journal science and immunology of allergy and primary over the past 17 years. Together with Dr Canonica, immune deficiencies with the clinical aspects of Dr Ballow has led the journal from its conception to disease recognition, evaluation, and treatment’. its current standing: a well respected source of infor- mation with an impact factor of 3.463. Dr Ballow’s Acknowledgements expertise and influence in the allergy and immunol- None. ogy field cannot be underestimated, nor can his commitment and dedication to the journal. He Financial support and sponsorship has been a pleasure to work with and will be a big None. loss to the journal. From all of us here at the editorial office: Mark, you will be missed. Conflicts of interest Second, welcome to Dr Susan Tarlo! Dr Tarlo has There are no conflicts of interest. been with the journal since 2003, working with Dr Piero Maestrelli to edit the very successful section on occupational disease. Dr Tarlo has been a wonderful REFERENCE servant to the journal over the years, and is a natural 1. Ballow M, Canonica GW. An introduction to current opinion in allergy and clinical immunology. Curr Opin Allergy Clin Immunol 2001; 1:1. successor to Dr Ballow. We look forward to seeing Health Learning, Research & Practice, Wolters Kluwer, London, UK Correspondence to Stephanie Fairbairn, Managing Editor, Health Learn- ing, Research & Practice, Wolters Kluwer, Citi Building, 41st Floor, 25 Canada Square, Canary Wharf, London E14 5LQ, UK. E-mail: Stephanie.Fairbairn@wolterskluwer.com Curr Opin Allergy Clin Immunol 2018, 18:167 DOI:10.1097/ACI.0000000000000449 1528-4050 Copyright  2018 Wolters Kluwer Health, Inc. All rights reserved. www.co-allergy.com Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

Journal

Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health

Published: Jun 1, 2018

There are no references for this article.